These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6133645)

  • 1. A review of ongoing trials of beta blockers in the secondary prevention of coronary heart disease.
    Cutler JA
    Circulation; 1983 Jun; 67(6 Pt 2):I62-5. PubMed ID: 6133645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The secondary prevention trials. Lessons learned, questions raised.
    Furberg CD
    Postgrad Med; 1988 Feb; Spec No():83-9. PubMed ID: 2894665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of beta-blockers in the acute phase of myocardial infarction].
    Marcillac-Desruennes M; Weber S; Degeorges M
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):519-23. PubMed ID: 6152138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with beta-blockers in patients with acute coronary syndrome].
    Nozawa T; Inoue H
    Nihon Rinsho; 1998 Oct; 56(10):2612-6. PubMed ID: 9796327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitation of infarct size by beta blockers and its potential role for prognosis.
    Hjalmarson A; Herlitz J
    Circulation; 1983 Jun; 67(6 Pt 2):I68-71. PubMed ID: 6133646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial infarction: secondary prevention with betablockers].
    Depelchin P; Hammoude H; Degré S
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):155-61. PubMed ID: 2567590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early intravenous beta blockade in acute myocardial infarction.
    Yusuf S
    Postgrad Med; 1988 Feb; Spec No():90-5. PubMed ID: 2894666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rest and the acutely ischaemic heart.
    Norris RM
    N Z Med J; 1980 Jul; 92(664):53-6. PubMed ID: 6107887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infarct size reduction: a review of clinical trials.
    Fitzsimons TJ
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S34-7. PubMed ID: 2483230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.